AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹12,480 Cr | ₹11,573 Cr | ₹9,966 Cr | ₹9,888 Cr | ₹9,075 Cr |
What is the latest Net Current Assets ratio of AUROBINDO PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹12,480 Cr |
| Mar2024 | ₹11,573 Cr |
| Mar2023 | ₹9,966 Cr |
| Mar2022 | ₹9,888 Cr |
| Mar2021 | ₹9,075 Cr |
How is Net Current Assets of AUROBINDO PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹12,480 Cr | 7.84 | |
| Mar2024 | ₹11,573 Cr | 16.12 | |
| Mar2023 | ₹9,966 Cr | 0.79 | |
| Mar2022 | ₹9,888 Cr | 8.96 | |
| Mar2021 | ₹9,075 Cr | - | |
Compare Net Current Assets of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹67,782.3 Cr | -4.8% | 0% | -6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,795.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -4.8% |
0% |
-6.5% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses